Skip to main content
HCPCS Level II/M-Codes/M1334

M1334 HCPCS Level II Code: Patients with a post-operative encounter of the eye with the acute pvd within 2 weeks before the initial encounter or 2 weeks after initial acute pvd encounter

Medicare Coverage & Payment

  • Medicare coverage: Carrier judgment (CMS coverage code C)
  • Payment category: Service not separately priced (pricing indicator 00)
  • BETOS: Z2
  • Effective: January 1, 2024

Source: CMS HCPCS Level II release. Coverage codes indicate how Medicare treats the code, not whether a specific claim will be paid; payer policy and documentation still govern.

Official Registry Overview & Definition

Patients with a post-operative encounter of the eye with the acute pvd within 2 weeks before the initial encounter or 2 weeks after initial acute pvd encounter is a HCPCS Level II code (M1334). CMS assigns coverage code C — Carrier judgment. Short description: Pts act pvd 2 wks 2 wks.

Nearest Codes in This Family

Official HCPCS Level II classifications closest to M1334 in its code family, with their registry titles.

  • M1329 — Patients with a post-operative encounter of the eye with the acute pvd within 2 weeks before the initial encounter or 8 weeks after initial acute pvd encounter
  • M1330 — Documentation of patient reason(s) for not having a follow up exam (e.g., inadequate time for follow up)
  • M1331 — Patients who were appropriately evaluated during the initial exam and were re-evaluated no later than 8 weeks from initial exam
  • M1332 — Patients who were not appropriately evaluated during the initial exam and/or who were not re-evaluated within 2 weeks
  • M1333 — Acute vitreous hemorrhage
  • M1335 — Documentation of patient reason(s) for not having a follow up exam (e.g., inadequate time for follow up)
  • M1336 — Patients who were appropriately evaluated during the initial exam and were re-evaluated no later than 2 weeks
  • M1337 — Acute pvd
  • M1338 — Patients who had follow-up assessment 30 to 180 days after the index assessment who did not demonstrate positive improvement or maintenance of functioning scores during the performance period
  • M1339 — Patients who had follow-up assessment 30 to 180 days after the index assessment who demonstrated positive improvement or maintenance of functioning scores during the performance period